434 related articles for article (PubMed ID: 34068970)
1. Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates.
Fakhri S; Nouri Z; Moradi SZ; Akkol EK; Piri S; Sobarzo-Sánchez E; Farzaei MH; Echeverría J
Molecules; 2021 May; 26(10):. PubMed ID: 34068970
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets.
Farahani M; Niknam Z; Mohammadi Amirabad L; Amiri-Dashatan N; Koushki M; Nemati M; Danesh Pouya F; Rezaei-Tavirani M; Rasmi Y; Tayebi L
Biomed Pharmacother; 2022 Jan; 145():112420. PubMed ID: 34801852
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine.
Dzobo K; Chiririwa H; Dandara C; Dzobo W
OMICS; 2021 Jan; 25(1):13-22. PubMed ID: 32857671
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.
Rana AK; Rahmatkar SN; Kumar A; Singh D
Cytokine Growth Factor Rev; 2021 Apr; 58():92-101. PubMed ID: 32948440
[TBL] [Abstract][Full Text] [Related]
5. Cellular host factors for SARS-CoV-2 infection.
Baggen J; Vanstreels E; Jansen S; Daelemans D
Nat Microbiol; 2021 Oct; 6(10):1219-1232. PubMed ID: 34471255
[TBL] [Abstract][Full Text] [Related]
6. The global succinylation of SARS-CoV-2-infected host cells reveals drug targets.
Liu Q; Wang H; Zhang H; Sui L; Li L; Xu W; Du S; Hao P; Jiang Y; Chen J; Qu X; Tian M; Zhao Y; Guo X; Wang X; Song W; Song G; Wei Z; Hou Z; Wang G; Sun M; Li X; Lu H; Zhuang X; Jin N; Zhao Y; Li C; Liao M
Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2123065119. PubMed ID: 35858407
[TBL] [Abstract][Full Text] [Related]
7. Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19.
van de Leemput J; Han Z
Mol Cell Biol; 2021 Aug; 41(9):e0018521. PubMed ID: 34124934
[TBL] [Abstract][Full Text] [Related]
8. Medical Significance of Uterine Corpus Endometrial Carcinoma Patients Infected With SARS-CoV-2 and Pharmacological Characteristics of Plumbagin.
Li Y; Yu S; Li Y; Liang X; Su M; Li R
Front Endocrinol (Lausanne); 2021; 12():714909. PubMed ID: 34712201
[TBL] [Abstract][Full Text] [Related]
9. H
Yang G
Am J Physiol Cell Physiol; 2020 Aug; 319(2):C244-C249. PubMed ID: 32515982
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication.
Chu J; Xing C; Du Y; Duan T; Liu S; Zhang P; Cheng C; Henley J; Liu X; Qian C; Yin B; Wang HY; Wang RF
Nat Metab; 2021 Nov; 3(11):1466-1475. PubMed ID: 34580494
[TBL] [Abstract][Full Text] [Related]
11. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
Rohilla S
Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
[TBL] [Abstract][Full Text] [Related]
12. Natural Products and Nutrients against Different Viral Diseases: Prospects in Prevention and Treatment of SARS-CoV-2.
Ali SG; Ansari MA; Alzohairy MA; Almatroudi A; Alomary MN; Alghamdi S; Rehman S; Khan HM
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33673004
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Malekmohammad K; Rafieian-Kopaei M
Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
[TBL] [Abstract][Full Text] [Related]
14. Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2.
Shahid M; Shahzad-Ul-Hussan S
J Struct Biol; 2021 Mar; 213(1):107690. PubMed ID: 33383190
[TBL] [Abstract][Full Text] [Related]
15. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F
Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786
[TBL] [Abstract][Full Text] [Related]
16. Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.
Blaess M; Kaiser L; Sommerfeld O; Csuk R; Deigner HP
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670304
[TBL] [Abstract][Full Text] [Related]
17. Host sphingolipids: Perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease.
Prakash H; Upadhyay D; Bandapalli OR; Jain A; Kleuser B
Prostaglandins Other Lipid Mediat; 2021 Feb; 152():106504. PubMed ID: 33147503
[TBL] [Abstract][Full Text] [Related]
18. A SARS-CoV-2 (COVID-19) biological network to find targets for drug repurposing.
Habibi M; Taheri G; Aghdam R
Sci Rep; 2021 Apr; 11(1):9378. PubMed ID: 33931664
[TBL] [Abstract][Full Text] [Related]
19. Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19.
Rajarshi K; Khan R; Singh MK; Ranjan T; Ray S; Ray S
Gene; 2021 Feb; 768():145313. PubMed ID: 33220345
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in potential drug therapies combating COVID-19 and related coronaviruses-A perspective.
Nile SH; Nile A; Jalde S; Kai G
Food Chem Toxicol; 2021 Aug; 154():112333. PubMed ID: 34118347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
